USD91.29 ₽ EUR98.07 ₽ telegram Telegram
2024-03-06 обновлены отчеты компании INO: 202320222021
Inovio Pharmaceuticals logo
Inovio Pharmaceuticals INO
$ 10.96 -1.7%

Inovio Pharmaceuticals Мультипликаторы 2011-2024 | INO

Мультипликаторы по годам Inovio Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.6 -0.1 -0.2 -10.3 -3.9 -4.8 -4.4 -6.1 -15.6 -13.7 -7.3 -4.4 -4.7

P/S

264.6 2.4 31.8 232.3 111.9 15.3 9.1 12.7 11.2 47.2 36.0 21.2 7.3

EPS

-6.1 -14.1 -17.4 -1.1 -1.2 -1.1 -1.1 -1.0 -0.4 -0.6 -1.4 -0.6 -0.1

EV (Enterprise Value)

259 млн 104 млн 81.5 млн 1.55 млрд 576 млн 487 млн 407 млн 481 млн 436 млн 473 млн 487 млн 92 млн 67.9 млн

EBITDA per Share

-6.37 -13.3 -17.1 -0.78 -1.07 -0.963 -0.993 -1.01 -0.489 -0.641 -0.422 -0.664 -0.64

EV/EBITDA

-2.2 1.8 -4.9 -5.0 -4.5 -5.8 -11.9 -11.9 -23.2 -3.6 -2.7

PEG

-0.0 -0.0 -0.0 -0.6 -0.25 1.73 -0.63 -0.05 0.53 0.24 -0.05 -0.27 0.16

P/B

1.9 0.1 0.1 3.7 85.1 5.4 2.7 3.6 2.6 4.4 9.2 2.5 1.5

P/CF

-1.8 -0.1 -0.3 -9.7 -4.7 -6.2 -5.3 -6.8 -29.9 -15.8 -31.2 -3.9 -3.6

ROE %

-115.14 -125.84 -75.98 -36.09 -2208.37 -111.42 -61.90 -59.77 -16.59 -32.39 -124.81 -56.43 -31.87

ROA %

-79.04 -80.28 -61.23 -30.83 -82.92 -73.96 -47.11 -42.45 -13.65 -27.41 -74.79 -43.57 -24.96

ROCE %

-122.66 -120.33 -75.37 -26.91 -99.24 -98.20 -55.75 -59.47 -19.35 -33.54 -36.32 -67.04 -44.39

Current Ratio

3.2 2.8 5.2 6.9 2.9 2.5 3.9 2.8 5.5 7.1 2.0 1.9 2.9

DSO

- - 1908.5 474.3 180.4 48.6 56.1 171.0 66.0 97.9 89.5 76.8 18.9

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

- - 1908.5 474.3 - - - - - - - - -

Финансовый цикл

- - 1908.5 474.3 - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Inovio Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.13 -0.13 -0.16 - -0.15 -0.46 -0.36 - -0.29 -0.39 -0.27 -0.14 0.12 -0.83 -0.26 -0.38 -0.23 -0.3 -0.3 -0.34 -0.27 -0.07 -0.36 -0.24 -0.39 -0.13 -0.31 -0.35 -0.28 -0.26 -0.11 -0.25 0.08 -0.09 -0.17 -0.12 -0.12 -0.18 -0.2 -0.3 -0.64 -0.24 -0.23 - -0.05 -0.03 -0.06 -0.04 -0.04 -0.02 -0.02

EBITDA per Share

- - -0.17 - -0.13 -0.43 -0.32 - -0.28 -0.39 -0.26 -0.16 -0.21 -0.2 -0.2 -0.3 -0.21 -0.27 -0.28 -0.3 -0.26 -0.04 -0.35 -0.25 -0.32 -0.11 -0.29 -0.3 -0.26 -0.24 -0.21 -0.2 0.06 -0.22 -0.13 -0.18 -0.13 -0.16 -0.18 -0.15 0.02 -0.12 -0.17 -0.04 -0.05 -0.05 -0.03 -0.04 -0.05 -0.04 -0.04

ROE %

-80.11 -69.72 -85.19 -72.89 -86.15 -85.25 -64.95 -38.77 -44.05 -26.63 -38.38 -36.09 -1127.20 -1803.55 -2631.14 -3474.70 -2416.22 -1772.80 -924.94 -111.54 -88.73 -83.92 -82.94 -61.95 -68.12 -60.99 -69.50 -59.81 -48.75 -28.73 -17.11 -16.61 -13.06 -22.70 -28.77 -32.48 -55.27 -107.69 -118.75 -125.88 -98.33 -58.74 -50.08 -57.25 -66.91 -57.23 -51.17 -32.24 -9.60 -5.96 -5.10

ROA %

-57.71 -49.78 -58.14 -51.01 -62.24 -63.83 -54.09 -33.42 -37.93 -23.14 -33.11 -30.83 -52.48 -72.08 -68.65 -82.92 -81.89 -84.93 -69.58 -73.96 -60.30 -59.45 -59.45 -47.11 -50.72 -44.45 -50.15 -42.45 -35.74 -21.18 -13.33 -13.65 -10.88 -18.94 -24.15 -27.41 -39.29 -68.82 -72.98 -74.79 -58.74 -38.44 -35.30 -43.57 -51.08 -43.84 -39.30 -24.96 -7.43 -4.62 -3.95

ROCE %

-83.07 -70.75 -83.86 -68.59 -81.81 -81.62 -63.00 -38.61 -44.98 -39.64 -30.47 -26.91 -906.14 -1595.53 -2409.29 -3234.51 -2382.85 -1716.23 -901.25 -108.23 -90.37 -80.22 -81.00 -58.74 -60.81 -56.69 -64.71 -61.84 -51.97 -33.46 -27.28 -19.51 -21.15 -30.76 -31.28 -35.51 -40.87 -31.92 -33.60 -37.26 -40.13 -59.90 -68.85 -68.39 -62.47 -57.55 -48.65 -45.73 -13.39 -10.86 -9.27

Current Ratio

3.5 3.7 4.0 2.8 3.1 2.8 4.9 5.2 6.5 7.1 8.9 6.9 6.9 6.9 6.9 1.0 1.0 1.0 1.0 3.0 3.0 3.0 3.0 4.2 4.2 4.2 4.2 3.5 3.5 3.5 3.5 5.6 5.6 5.6 5.6 6.5 6.5 6.5 6.5 2.5 2.5 2.5 2.5 4.4 4.4 4.4 4.4 4.6 4.6 4.6 4.6

DSO

- - 704.6 - 34.5 493.6 2170.5 - 2799.6 3853.1 1688.7 1818.8 1888.7 1586.7 2109.5 108.7 100.2 84.6 292.9 120.9 535.6 583.6 278.0 62.3 207.1 26.8 96.0 169.6 115.1 232.7 130.1 112.5 27.7 126.6 89.5 104.1 139.0 67.3 118.2 173.2 31.8 383.5 129.6 66.8 88.7 173.8 35.0 26.1 16.2 17.6 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - 704.6 - 34.5 493.6 2170.5 - 2799.6 3853.1 1688.7 1818.8 1888.7 1586.7 2109.5 108.7 100.2 84.6 292.9 120.9 535.6 583.6 278.0 62.3 207.1 26.8 96.0 169.6 115.1 232.7 130.1 112.5 27.7 126.6 89.5 104.1 139.0 67.3 118.2 173.2 31.8 383.5 129.6 66.8 88.7 173.8 35.0 26.1 16.2 17.6 -

Финансовый цикл

- - 704.6 - 34.5 493.6 2170.5 - 2799.6 3853.1 1688.7 1818.8 1888.7 1586.7 2109.5 108.7 100.2 84.6 292.9 120.9 535.6 583.6 278.0 62.3 207.1 26.8 96.0 169.6 115.1 232.7 130.1 112.5 27.7 126.6 89.5 104.1 139.0 67.3 118.2 173.2 31.8 383.5 129.6 66.8 88.7 173.8 35.0 26.1 16.2 17.6 -

Все данные представлены в валюте USD